• English
    • Norsk
  • English 
    • English
    • Norsk
  • Administration
View Item 
  •   Home
  • Det medisinske fakultet
  • Profesjonsstudiet medisin
  • Medisinsk genetikk
  • View Item
  •   Home
  • Det medisinske fakultet
  • Profesjonsstudiet medisin
  • Medisinsk genetikk
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Genterapi ved iskemisk hjertesykdom : en drøfting av aktuell metodikk og utfordringer

Kerboeuf, Stephan Marius Bertrand Kolmannskog
Master thesis
View/Open
Proskjektoppgavex11.xsemester.pdf (725.3Kb)
Year
2012
Permanent link
http://urn.nb.no/URN:NBN:no-30875

Metadata
Show metadata
Appears in the following Collection
  • Medisinsk genetikk [14]
Abstract
Cardiovascular diseases are a heterogeneous group of diseases whish still remains a major health problem in the healthcare system. This review merely focuses on the issue of ischemic heart disease and it’s complications, but mentions other cardiovascular diseases in a shallow matter. The traditional way of treating coronary artery disease has involved pharmacological methods and revascularization through percutaneous coronary interventions (PCI) and bypass graft surgery. Not all patients are amendable to revascularization procedures, and would welcome alternative therapies. Many patients will with or without successful revascularization develop chronic hearth failure over time. This is a serious disease with generally bad prognosis. We will address a new treatment strategy; gene therapy, and it’s potential use as a therapeutic agent primarily for patients with ischemic heart disease, but also for patients with a variety of other cardiovascular diseases. The different vector systems for delivery of therapeutic genes are discussed, as well as their capability of targeting the myocardium in a highly specific way. Viral and non-viral vectors have their “pros and cons”, and these are considered in the overview. Potential target genes for therapy are also discussed, focusing primarily on genes affecting the process of angiogenesis and arteriogenesis, and especially hypoxia-inducible factor-1 (HIF-1) and the hypoxia-responsive genes it regulates. Choices of gene delivery methods are discussed.
 
Responsible for this website 
University of Oslo Library


Contact Us 
duo-hjelp@ub.uio.no


Privacy policy
 

 

For students / employeesSubmit master thesisAccess to restricted material

Browse

All of DUOCommunities & CollectionsBy Issue DateAuthorsTitlesThis CollectionBy Issue DateAuthorsTitles

For library staff

Login
RSS Feeds
 
Responsible for this website 
University of Oslo Library


Contact Us 
duo-hjelp@ub.uio.no


Privacy policy